Singular Genomics Systems (OMIC) - Sof marja

Singular Genomics Systems Inc (OMIC) grafik logotipi

Singular Genomics Systems (OMIC) mustaqil mahsulot sikli asosida faoliyat yuritadi, bu esa kompaniyani defensiv aktiv sifatida shakllantiradi. Ushbu grafikdagi nisbiy sof savdo foydasi ushbu barqarorlikni vizuallashtiradi, bunda -3237.90 ko'rsatkichning joriy darajasini ifodalaydi. Biroq, geosiyosiy keskinliklar va sanksiyalar xomashyo ta'minotiga ta'sir qilishi mumkin. Ushbu xatarlar elektronika yig'ish va logistikani uchinchi tomon pudratchilariga autsorsing qilish orqali yumshatiladi.

Singular Genomics Corp (OMIC) Sof foyda bo'yicha sotuv rentabelligi: 04.07.2022 - 01.03.2025 davri uchun

Singular Genomics Corp (OMIC) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

Kompaniyaning barcha koʻrsatkichlari tahlili:Singular Genomics, OMIC
Singular Genomics Systems Inc yetakchi tovari

Investorlar ushbu ko'rsatkichdan tushumni sof foydaga aylantirish samaradorligini baholash uchun foydalanadilar. Ushbu metrika sof foydaning umumiy savdo hajmidagi nisbati sifatida hisoblanadi. Sof foyda marjasini tahlil qilish orqali topilgan har bir dollarning haqiqiy qiymatini aniqlash mumkin. Singular Genomics Systems (OMIC) uchun ushbu raqam G4 tizimlarini joriy etishdan olingan rentabellikni aks ettiradi. Ilmiy institutlar bilan sinergiya biznesning yakuniy marjalariga bevosita ta'sir ko'rsatadi.

Singular Genomics Systems kimlar bilan raqobatlashadi

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|Stoke Therapeutics Inc (STOK) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi BLFS|Sof marja WVE (Wave Life Sciences Corp)|Sof marja Maze Therapeutics MAZE|Sof foyda normasi SION|PRME - Sof marja|Kompaniya sotuv marjasi Taysha TSHA|QURE: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MeiraGTx PLC|RGNX (REGENXBIO Inc) - Sotuvning sof marjinal rentabelligi|solidbio.com (SLDB) - Kompaniya sotuv marjasi|Sof marja Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning sof rentabelligi|Benitec Biopharma - Sof foyda bo'yicha sotuv rentabelligi|DSGN: Sotuvning sof rentabelligi|RCKT: Sof foyda bo'yicha sotuv rentabelligi|FDMT - Sotuvning sof marjinal rentabelligi|LXEO: Sotuvning sof marjinal rentabelligi|Korro Bio Inc. - Sof foyda normasi|EDIT (editasmedicine.com) - Sotuvning sof marjinal rentabelligi|Sof marja SLN|Sof marja ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning sof rentabelligi|Sof marja Sangamo SGMO|NAUT: Sotuvning sof rentabelligi|MGX: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Precision BioSciences|GBIO (generationbio.com) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IMNN (Imunon, Inc.)|Sotuvning sof marjinal rentabelligi PHIO|MBIO - Sof marja|Sotuvning sof marjinal rentabelligi RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Sof marja|Applied DNA - Sotuvning sof marjinal rentabelligi|Sof marja Bluebird Bio|ImmunoPrecise (IPA) - Sof marja|Sof foyda marjasi OMGA (Omega)|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX